The prediction of survival in Gastric Cancer based on a Robust 13-Gene Signature.

Wang, Guoguang; Zhan, Tian; Li, Fan; Shen, Jian; Gao, Xiang; Xu, Lei; Li, Yuan; Zhang, Jianping

Wang, Guoguang; Zhan, Tian; Li, Fan; Shen, Jian; Gao, Xiang; Xu, Lei; Li, Yuan; Zhang, Jianping.

Afiliação

Wang G; Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhan T; Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Li F; Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Shen J; Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Gao X; Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xu L; Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Li Y; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China.
Zhang J; Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.

J Cancer ; 12(11): 3344-3353, 2021.

Article em En | MEDLINE | ID: mdl-33976744

Palavras-chave

Kyoto Encyclopedia of Genes and Genomes pathway; drug resistance; gastric cancer; prognostic signature; recurrence

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Cancer Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google